title: Comparison of four prognostic scores in peripheral T-cell lymphoma.
abstract: BACKGROUND
  To compare the usefulness of four prognostic scores in patients with peripheral T-cell lymphoma (PTCL) from a single institution.
  
  
  METHODS
  One hundred twenty-one patients (77 male/36 female, median age 53 years) with PTCL [anaplastic large-cell lymphoma (ALCL) 21, PTCL not otherwise specified 56 and other 44)]. Complete response (CR) rate and 5-year overall survival (OS) were 41% and 31%, respectively. International Prognostic Index (IPI), Prognostic Index for T-cell lymphoma (PIT), International peripheral T-cell lymphoma Project score (IPTCLP) and modified Prognostic Index for T-cell lymphoma (mPIT) were calculated as in the original references. mPIT was only assembled to 41 patients in whom Ki-67 immunostaining was available. ALCL patients were analyzed separately.
  
  
  RESULTS
  Concordance among IPI, PIT and IPTCLP was 52% for low-risk group, 27% for low/intermediate-risk group, 20% for high/intermediate-risk group and 14% for high-risk group. IPI, PIT and IPTCLP predicted CR, with IPI being the best score in logistic regression. Neither Ki-67 immunostaining nor mPIT predicted CR. Five-year OS (low-risk versus intermediate- or high-risk categories) according to IPI, PIT, IPTCLP and mPIT were 52% versus 45%, 75% versus 49%, 58% versus 20% and 39% versus 0%, respectively. IPTCLP was the best score for OS in multivariate analysis.
  
  
  CONCLUSIONS
  All the scores demonstrated their usefulness to assess the outcome of patients with PTCL, with IPTCLP being the most significant to predict OS.
authors.affiliation: Department of Hematology, Institut de Recerca Biome`dica August Pi i Sunyer, Barcelona, Spain.
authors.forename: G
authors.initials: G
authors.lastname: Gutiérrez-García
authors.forename: A
authors.initials: A
authors.lastname: García-Herrera
authors.forename: T
authors.initials: T
authors.lastname: Cardesa
authors.forename: A
authors.initials: A
authors.lastname: Martínez
authors.forename: N
authors.initials: N
authors.lastname: Villamor
authors.forename: G
authors.initials: G
authors.lastname: Ghita
authors.forename: A
authors.initials: A
authors.lastname: Martínez-Trillos
authors.forename: L
authors.initials: L
authors.lastname: Colomo
authors.forename: X
authors.initials: X
authors.lastname: Setoain
authors.forename: S
authors.initials: S
authors.lastname: Rodríguez
authors.forename: E
authors.initials: E
authors.lastname: Giné
authors.forename: E
authors.initials: E
authors.lastname: Campo
authors.forename: A
authors.initials: A
authors.lastname: López-Guillermo
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D006801:Humans; D016399:Lymphoma, T-Cell / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D055815:Young Adult